Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis

James del Rosso; Pearl Kwong; Iftikhar Hussain; Sebastien Barbarot; Jose Carrascosa; Maria Rueda; Amber Atwater; Hany Elmaraghy; Luna Sun; Sherry Chen; Chitra Natalie; Stephan Weidinger

doi:10.25251/skin.7.supp.147

Journal Articles SKIN The Journal of Cutaneous Medicine Year : 2023

Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis

(1) , (2) , (3) , (4) , (5) , (6) , (6) , (6) , (6) , (7) , (6) , (8)

1
2
3
4
5
6
7
8

James del Rosso

Function : Author

JDR Dermatology Research

Pearl Kwong

Function : Author

Solutions Through Advanced Research

Iftikhar Hussain

Function : Author

Department of Wildlife Management

Sebastien Barbarot

Function : Author

Physiopathologie des Adaptations Nutritionnelles

Jose Carrascosa

Function : Author

Department of Structure of Macromolecules

Maria Rueda

Function : Author

Eli Lilly and Company [Indianapolis]

Amber Atwater

Function : Author

Eli Lilly and Company [Indianapolis]

Hany Elmaraghy

Function : Author

Eli Lilly and Company [Indianapolis]

Luna Sun

Function : Author

Eli Lilly and Company [Indianapolis]

Sherry Chen

Function : Author

Tigermed

Chitra Natalie

Function : Author

Eli Lilly and Company [Indianapolis]

Stephan Weidinger

Function : Author

University Hospital Schleswig-Holstein

Keywords

Lebrikizumab Atopic Dermatitis

Domains

Life Sciences [q-bio]

Fichier principal

1949-Article Text-11880-1-10-20230313.pdf (1.03 Mo)

Origin	Publisher files allowed on an open archive
Licence	Attribution

Pascal Lallemant : Connect in order to contact the contributor

https://hal.inrae.fr/hal-04248019

Submitted on : Thursday, October 19, 2023-9:51:41 AM

Last modification on : Friday, April 12, 2024-6:32:06 PM

Long-term archiving on: Saturday, January 20, 2024-6:21:14 PM

Dates and versions

hal-04248019 , version 1 (19-10-2023)

Licence

Attribution

Identifiers

HAL Id : hal-04248019 , version 1
DOI : 10.25251/skin.7.supp.147

Cite

James del Rosso, Pearl Kwong, Iftikhar Hussain, Sebastien Barbarot, Jose Carrascosa, et al.. Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 2023, 7 (2), pp.s147. ⟨10.25251/skin.7.supp.147⟩. ⟨hal-04248019⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INRAE PHAN NANTES-UNIVERSITE UFR-MEDECINE-NANTES

18 View

14 Download

Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis

Keywords

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share